
Hypothesis: Bradykinin Blockers Might Reduce the Need for Ventilators for COVID-19 Patients
Author(s) -
Olusayo Louise Oluwasanmi
Publication year - 2020
Publication title -
journal of advances in medicine and medical research
Language(s) - English
Resource type - Journals
ISSN - 2456-8899
DOI - 10.9734/jammr/2020/v32i1230537
Subject(s) - bradykinin , covid-19 , medicine , case fatality rate , pulmonary edema , intensive care medicine , anesthesia , lung , virology , infectious disease (medical specialty) , receptor , disease , epidemiology , outbreak
The symptoms of COVID-19, leading to pulmonary edema and the need for ventilators may be due to the fact that the virus increases bradykinin levels. If true, administering bradykinin blockers can provide a cheap way to reduce the severity of the symptoms and the burden on hospital resources, and, ultimately, the fatality rate.